{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-066974","form_type":"8-K","ticker":"CBLL","cik":"0001861107","company_name":"Ceribell, Inc.","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.228290+00:00","generated_at":"2026-05-22T05:33:53.153433+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Ceribell Q1 revenue $20.5M (+42% YoY); raises FY2025 guidance to $83-87M","bullets":["Q1 total revenue $20.5M (+42% YoY); product $15.6M (+41%), subscription $4.9M (+45%).","Net loss $12.8M ($0.36 diluted EPS) vs $8.5M ($1.56) YoY; gross margin 88% (86% prior year).","Raised 2025 revenue guidance to $83-87M (27-33% growth over prior year).","Cash and marketable securities $182.7M; 558 active accounts at quarter end.","FDA 510(k) clearance for pediatric Clarity algorithm (ages 1+); received FedRAMP High authorization."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-066974","json":"https://secwatch.observer/filing/0000950170-25-066974.json","markdown":"https://secwatch.observer/filing/0000950170-25-066974.md","text":"https://secwatch.observer/filing/0000950170-25-066974.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861107/000095017025066974/0000950170-25-066974-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861107/000095017025066974/cbll-20250508.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T05:33:53.153433+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}